Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
PRAX
PRAX News & Events
-
Add to Watchlist
Trade PRAX
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
PRAX News
Praxis Precision Medicines Appoints Dr. Orrin Devinsky as Head of Clinical Strategy
Jan 13 2026
Globenewswire
Praxis Grants 434 Restricted Stock Units to Attract New Employees
Jan 09 2026
Globenewswire
Praxis Grants 434 Restricted Stock Units to New Employees Under 2024 Inducement Plan
Jan 09 2026
Yahoo Finance
Praxis Appoints New Board Members and Promotes Executives to Enhance Growth Strategy
Jan 08 2026
Globenewswire
Bright Minds Biosciences Launches $100 Million Public Offering
Jan 07 2026
Benzinga
Praxis Precision Medicines Prices Underwritten Public Offering, Amount Undisclosed
Jan 07 2026
Yahoo Finance
Praxis Precision Medicines Prices 2.21M Share Offering at $260, Raising Approximately $575M
Jan 07 2026
NASDAQ.COM
Praxis Precision Medicines Prices 2.21M Share Offering at $260 Each
Jan 07 2026
Globenewswire
Show More News
PRAX Events
No data
PRAX Monitor News
Praxis Precision Medicines Inc rises as it crosses above 5-day SMA
Jan 27 2026
Praxis Precision Medicines falls amid sector rotation
Jan 26 2026
Praxis Precision Medicines Appoints Dr. Orrin Devinsky as Head of Clinical Strategy
Jan 16 2026
Praxis Precision Medicines Appoints Dr. Orrin Devinsky as Head of Clinical Strategy
Jan 14 2026
Praxis Precision Medicines Prices $575M Share Offering
Jan 12 2026
Praxis Precision Medicines raises $575 million through share offering
Jan 07 2026
Praxis Receives FDA Breakthrough Therapy Designation for Ulixacaltamide
Dec 29 2025
Praxis Precision Medicines Inc Hits 52-Week High on EMBOLD Study Success
Dec 05 2025
Show More Monitor News
PRAX Earnings Analysis
No Data
People Also Watch
